RWMG
RGNX icon

Redwood Wealth Management Group’s Regenxbio RGNX Stock Holding History

Redwood Wealth Management Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,385
Closed -$250K – 187
2025
Q4 		$250K Buy
+17,385
New +$217K 0.1% 155
2024
Q3 		– Sell
-13,360
Closed -$156K – 872
2024
Q2 		$156K Hold
13,360
– – 0.12% 141
2024
Q1 		$281K Sell
13,360
-300
-2% -$5.34K 0.3% 93
2023
Q4 		$245K Sell
13,660
-700
-5% -$12.3K 0.27% 101
2023
Q3 		$236K Sell
14,360
-400
-3% -$7.25K 0.28% 103
2023
Q2 		$295K Sell
14,760
-430
-3% -$8.29K 0.33% 86
2023
Q1 		$287K Sell
15,190
-100
-0.7% -$2.21K 0.33% 91
2022
Q4 		$347K Buy
+15,290
New +$346K 0.43% 68

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return